NOVAST LABS FDA Approval ANDA 209675

ANDA 209675

NOVAST LABS

FDA Drug Application

Application #209675

Application Sponsors

ANDA 209675NOVAST LABS

Marketing Status

Prescription001

Application Products

001TABLET, EXTENDED RELEASE;ORAL0.1MG0CLONIDINE HYDROCHLORIDECLONIDINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2019-03-05STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB1

CDER Filings

NOVAST LABS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 209675
            [companyName] => NOVAST LABS
            [docInserts] => ["",""]
            [products] => [{"drugName":"CLONIDINE HYDROCHLORIDE","activeIngredients":"CLONIDINE HYDROCHLORIDE","strength":"0.1MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"03\/05\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"08\/14\/2020","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2020-08-14
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.